In conclusion, our work demonstrates that Prp19 acts as an oncogene, and its overexpression promotes invasion by inducing EMT via, at least partially, the p38 MAPK/Twist1-dependent pathway in HCC. Here, PRPF19 is linked to hepatocellular carcinoma.